Skip to content

A Comprehensive Report for decision making

Drug Developer's Intelligence Report

Oncology DRUG REPORT

2017

Latest Updated Report available for Purchase

RELEASED - JANUARY 2017

Download TOC1 MB
Check Discount Price
Add to Cart

1047

Oncology Drug Developers

It is an excellent report that has a wide variety of oncology information all in one place.

- Dr. Oleh Denysyk

Third Updated Edition - oncology intelligence 2017 Report

Report to Cover all Aspects of Cancer Drug Development Intelligence

COMPANIES * MOLECULES * INDICATIONS * TECHNOLOGIES * DEALS * FUNDING

OI 2017 Vs OI 2014
(in terms of Oncology Drug Developers Number)

UPDATED DATA for
ACCURATE DECISIONS

 

OI 2017 is a key update over previous report OI 2014, as it may covers 220 more oncology drug developers than the previous report. It also abandoned 103 companies, which were earlier covered in OI 2014, which were either acquired/merged or closed during the period.

largest coverage

providing intelligence at fingertips

Countries
1

Largest Coverage with 32 Countries covered Globally

Drug developers
1

523 Clinical, 360 Preclinical Companies Profiles

Molecules
1 +

Individual Drug Mechanism of Action & Drug Target

Cancer Targets
1 +

Emerging Cancer Drug Targets Details

intelligence supercharged

1055 pages full of insights

Other Reports in this series

For Purchase, Kindly check the latest report available in this series...

Oncology Intelligence 2013
Comprehensive Decision Making Intelligence derived from Active 624 Oncology Drug Developers.
Further Details
Oncology Intelligence 2014
Comprehensive Decision Making Intelligence derived from Active 931 Oncology Drug Developers.
Further Details
Oncology Intelligence 2017
Comprehensive Decision Making Intelligence derived from Active 1047 Oncology Drug Developers.
Further Details
Oncology Drug Report 2020
Comprehensive Decision Making Intelligence derived from Active 1610 Oncology Drug Developers.
Further Details
Oncology Drug Report 2021
Comprehensive Decision Making Intelligence derived from Active 2010 Oncology Drug Developers.
Further Details
Oncology Drug Report 2022
Upcoming Comprehensive Decision Making Report derived from Active 2300+ Oncology Drug Developers.
Further Details
January 2013
March 2014
January 2017
Feburary 2020
May 2021
March 2022